Kathleen I. Pishas
305 Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status.
Journal: International journal of molecular sciences
Published: December 13, 2025
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile.
Journal: The Journal of pathology
Published: October 28, 2025
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens.
Journal: Briefings in bioinformatics
Published: July 17, 2025
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing.
Journal: NPJ genomic medicine
Published: April 22, 2024
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: November 21, 2023
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 14, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Journal: Histopathology
Published: November 24, 2022
Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma.
Journal: Molecular cancer research : MCR
Published: January 11, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.
Journal: NPJ precision oncology
Published: December 29, 2021
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Journal: Nature genetics
Published: November 22, 2021
Last Updated: 09/26/2026